- Home
- BAK vs GRDN Comparison
BAK vs GRDN Comparison
Compare BAK & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAK
- GRDN
- Stock Information
- Founded
- BAK 1972
- GRDN 2004
- Country
- BAK Brazil
- GRDN United States
- Employees
- BAK N/A
- GRDN N/A
- Industry
- BAK Major Chemicals
- GRDN Retail-Drug Stores and Proprietary Stores
- Sector
- BAK Industrials
- GRDN Consumer Staples
- Exchange
- BAK Nasdaq
- GRDN Nasdaq
- Market Cap
- BAK 1.4B
- GRDN 1.6B
- IPO Year
- BAK N/A
- GRDN 2024
- Fundamental
- Price
- BAK $3.56
- GRDN $20.50
- Analyst Decision
- BAK Strong Buy
- GRDN Strong Buy
- Analyst Count
- BAK 3
- GRDN 2
- Target Price
- BAK $9.75
- GRDN $24.50
- AVG Volume (30 Days)
- BAK 1.1M
- GRDN 267.8K
- Earning Date
- BAK 08-06-2025
- GRDN 08-15-2025
- Dividend Yield
- BAK N/A
- GRDN N/A
- EPS Growth
- BAK N/A
- GRDN N/A
- EPS
- BAK N/A
- GRDN N/A
- Revenue
- BAK $13,770,122,923.00
- GRDN $1,282,307,000.00
- Revenue This Year
- BAK $18.11
- GRDN $12.01
- Revenue Next Year
- BAK $7.32
- GRDN $2.33
- P/E Ratio
- BAK N/A
- GRDN N/A
- Revenue Growth
- BAK 14.35
- GRDN 19.55
- 52 Week Low
- BAK $2.85
- GRDN $14.16
- 52 Week High
- BAK $7.71
- GRDN $26.91
- Technical
- Relative Strength Index (RSI)
- BAK 51.91
- GRDN N/A
- Support Level
- BAK $3.27
- GRDN N/A
- Resistance Level
- BAK $3.80
- GRDN N/A
- Average True Range (ATR)
- BAK 0.11
- GRDN 0.00
- MACD
- BAK 0.04
- GRDN 0.00
- Stochastic Oscillator
- BAK 63.28
- GRDN 0.00
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.